MERCN.E — Mercan Kimya Sanayi ve Ticaret AS Balance Sheet
0.000.00%
- TRY3.40bn
- TRY4.02bn
- TRY2.63bn
- 64
- 28
- 45
- 39
Annual balance sheet for Mercan Kimya Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 18.2 | 111 | 312 | 336 | 210 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 97.3 | 185 | 503 | 804 | 497 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 200 | 517 | 1,424 | 1,739 | 1,010 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 31.5 | 84.9 | 366 | 866 | 872 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 282 | 669 | 2,076 | 3,353 | 2,714 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 155 | 279 | 839 | 1,361 | 884 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 208 | 311 | 856 | 1,462 | 928 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 74 | 358 | 1,220 | 1,891 | 1,786 |
| Total Liabilities & Shareholders' Equity | 282 | 669 | 2,076 | 3,353 | 2,714 |
| Total Common Shares Outstanding |